Compare HIX & NUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HIX | NUS |
|---|---|---|
| Founded | 1998 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Other Pharmaceuticals |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 376.5M | 347.0M |
| IPO Year | 1998 | 1996 |
| Metric | HIX | NUS |
|---|---|---|
| Price | $3.90 | $7.25 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 318.2K | ★ 455.4K |
| Earning Date | 01-01-0001 | 05-07-2026 |
| Dividend Yield | ★ 13.14% | 3.35% |
| EPS Growth | N/A | ★ 207.80 |
| EPS | N/A | ★ 3.18 |
| Revenue | N/A | ★ $3,176,718,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $7.14 |
| P/E Ratio | ★ N/A | $2.26 |
| Revenue Growth | N/A | ★ 48.98 |
| 52 Week Low | $3.65 | $5.32 |
| 52 Week High | $4.39 | $14.62 |
| Indicator | HIX | NUS |
|---|---|---|
| Relative Strength Index (RSI) | 33.35 | 28.36 |
| Support Level | $3.88 | $7.18 |
| Resistance Level | $4.26 | $10.99 |
| Average True Range (ATR) | 0.06 | 0.25 |
| MACD | -0.01 | 0.07 |
| Stochastic Oscillator | 5.77 | 26.25 |
Western Asset High Income Fund II Inc is a diversified closed-end management investment company. Its investment objective is to maximize current income by investing at least 80% of its net assets and borrowings for investment purposes in high-yield debt securities.
Nu Skin Enterprises Inc develops and distributes a comprehensive line of beauty and wellness solutions in various countries. The company operates in two primary product categories: beauty and wellness products. Additionally, the company also operates through its subsidiary, Rhyz. It reports revenue from nine segments, consisting of its seven geographic Nu Skin segments: Americas, Southeast Asia/Pacific, Mainland China, Japan, Europe & Africa, South Korea, and Hong Kong/Taiwan and two Rhyz segments: manufacturing, which includes manufacturing and packaging subsidiaries it has acquired; and Rhyz Other, which includes other investments by its Rhyz strategic investment arm. The majority of the company's revenue is generated from the Wellness product category from the Americas segment.